🇺🇸 FDA
Patent

US 8889882

Process for preparing biphenyl imidazole compounds

granted A61PA61P29/00A61P43/00

Quick answer

US patent 8889882 (Process for preparing biphenyl imidazole compounds) held by Theravance Biopharma R&D IP, LLC expires Mon Nov 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance Biopharma R&D IP, LLC
Grant date
Tue Nov 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P29/00, A61P43/00, A61P9/12